Global Health (MEDANTA) Share Price Falls 2.08% Today; MEDANTA Ends at Rs 1,404
- September 29, 2026
- Posted by: Harsh Piplani
- Category: News
Global Health Share Price was under focus on 29 September 2026 after MEDANTA ended at Rs 1,404, down 2.08% from the previous close of Rs 1,433.80. The stock’s market capitalisation stood at Rs 40,204.85 Cr, keeping it in the Large Cap category. The move made Global Health Share Price Today relevant for investors tracking stock news, especially because the supplied data confirms the price event but does not establish a company-specific catalyst.
For readers scanning Global Health Stock News or Global Health Share Price News, the day’s decline also needs to be read alongside the session range, valuation, and healthcare sector context. The stock opened at Rs 1,441.65, touched a high of Rs 1,451.10 and a low of Rs 1,402 before closing at Rs 1,404. The following sections break down the Global Health Share Price move, the fundamental setup, sector comparison and what investors should monitor next on Univest.
Global Health (MEDANTA) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,404 |
| Previous Close | Rs 1,433.8 |
| Today's Move | -Rs 29.80 (-2.08%) |
| Open | Rs 1,441.65 |
| High | Rs 1,451.1 |
| Low | Rs 1,402 |
| Turnover | Rs 1.04 crore |
| Market Capitalisation | Rs 40,204.85 crore |
| Market Cap Category | Large Cap |
Global Health Share Price Today moved lower by Rs 29.80, or 2.08%, to Rs 1,404 from the previous close of Rs 1,433.80. The session opened at Rs 1,441.65, which was above the previous close, and the stock briefly moved to Rs 1,451.10 before slipping to a low of Rs 1,402. That range shows the day’s trading stayed close to the lower end of the session, with the final close only slightly above the intraday low.
Turnover stood at Rs 1.04 Cr. The market-cap category is Large Cap, while the exact market capitalisation was Rs 40,204.85 Cr. In share price terms, the day’s move left Global Health Share Price below the open and also below the previous close. For investors following Global Health Share Price Live, the key factual takeaway is simple: the stock ended lower on the day, and the supplied data does not identify a company-specific trigger.
That makes the next step a look at the company’s financial profile and where MEDANTA sits inside its healthcare peer group through a broader stock analysis lens.
Global Health (MEDANTA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 40,204.85 crore |
| P/E Ratio | 69.31x |
| P/B Ratio | 9.38x |
| ROE | 15.12% |
| ROCE | 19.38% |
| EPS | Rs 20.69 |
| Book Value Per Share | Rs 152.94 |
| Dividend Yield | 0.03% |
These figures place Global Health Share Price in a premium valuation zone relative to the sector median discussed later, while ROE of 15.12% and ROCE of 19.38% show that return ratios are well defined in the data. The P/E multiple is materially above the broader healthcare industry median, and the P/B multiple is also above the industry median. That combination helps explain why Global Health Stock Analysis stays valuation-sensitive even when daily price changes are modest in absolute terms.
For investors comparing Global Health Financial Results and fundamentals with other healthcare names, the exact ratios matter more than any headline move. The numbers here give context to Global Health Share Price Fall without turning that move into a forecast or rating. Univest uses these figures to anchor factual analysis, not to infer direction beyond what the data supports.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Hospital & Healthcare Services |
| Benchmark Scope | same industry |
| Company P/E Ratio | 69.31x |
| Benchmark Median P/E | 47.3x |
| Benchmark Average P/E | 99.87x |
| Benchmark P/E Range | 6.96x to 1,591.61x |
| Company P/B Ratio | 9.38x |
| Benchmark Median P/B | 3.93x |
| Benchmark Average P/B | 4.7x |
| Company ROE | 15.12% |
| Benchmark Median ROE | 13.01% |
| Benchmark Average ROE | 12.87% |
| Company ROCE | 19.38% |
| Benchmark Median ROCE | 15.84% |
| Benchmark Average ROCE | 2.83% |
| Company Market Capitalisation | Rs 40,204.85 crore |
| Benchmark Median Market Cap | Rs 589.78 crore |
| Benchmark Average Market Cap | Rs 11,484.52 crore |
The healthcare sector view is important because Global Health Share Price should be read against the same industry benchmark. The benchmark scope is the same industry, covering 65 companies. Within that set, MEDANTA’s P/E ratio of 69.31 is above the peer-group median of 47.3 and below the benchmark average of 99.87. Its P/B ratio of 9.38 is above the benchmark median of 3.93 and above the benchmark average of 4.7.
Return ratios also provide useful context. Global Health ’s ROE of 15.12% is above the benchmark median of 13.01%, and ROCE of 19.38% is above the benchmark median of 15.84%. On market capitalisation, MEDANTA’s Rs 40,204.85 Cr sits well above the benchmark median of Rs 589.78 Cr and below the benchmark average of Rs 11,484.52 Cr, reflecting the presence of a few very large peers in the same industry.
In sector terms, the comparison suggests that Global Health Share Price is supported by a sizeable healthcare platform with valuation levels that remain above the industry centre of gravity. The healthcare sector and the Hospital & Healthcare Services industry remain the right reference points for any further Global Health Stock News monitoring.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Apollo Hospitals Enterprise | APOLLOHOSP | 1,27,823.12 | 60.98 | 13.16 | 23.54 | 21.73 |
| Max Healthcare Institute | MAXHEALTH | 98,693.66 | 66.87 | 8.91 | 14.53 | 14.97 |
| MANIPAL HEALTH ENTERPRI L | MANIPALHOS | 95,621.35 | 106.43 | 5.21 | 12.95 | 13.93 |
| Aster DM Healthcare | ASTERDM | 66,181.73 | 204.54 | 15.41 | 13.07 | 16.22 |
| Fortis Healthcare | FORTIS | 63,046.55 | 59.91 | 6.18 | 11.32 | 14.07 |
Peer comparison gives additional context for Global Health Share Price Today. MEDANTA’s P/E of 69.31 sits above Fortis Healthcare at 59.91 and Apollo Hospitals Enterprise at 60.98, but below Manipal Health Enterpri L at 106.43 and Aster DM Healthcare at 204.54. It is also close to Max Healthcare Institute at 66.87.
On valuation versus profitability, Global Health ROE of 15.12% is below Apollo Hospitals at 23.54% and Dr. Lal Pathlabs at 22.37%, but above Max Healthcare at 14.53%, Fortis at 11.32% and Manipal Health at 12.95%. ROCE of 19.38% is above Max Healthcare at 14.97%, Fortis at 14.07% and Manipal Health at 13.93%, and below Apollo Hospitals at 21.73% and Dr. Lal Pathlabs at 29.56%.
By market capitalisation, MEDANTA at Rs 40,204.85 Cr is smaller than Apollo Hospitals and Max Healthcare, but larger than Fortis, Manipal Health, Aster DM Healthcare, Narayana Hrudayalaya, Dr. Lal Pathlabs and Krishna Institute of Medical Sciences That mix keeps Global Health Stock Performance in the middle of a highly valued healthcare peer set.
Why Investors Are Watching Global Health
- Global Health Share Price fell 2.08% today to Rs 1,404 from Rs 1,433.80.
- The stock opened at Rs 1,441.65 and traded between Rs 1,451.10 and Rs 1,402 in the session.
- Market capitalisation stood at Rs 40,204.85 Cr, placing MEDANTA in the Large Cap category.
- P/E was 69.31, P/B was 9.38, ROE was 15.12% and ROCE was 19.38%.
- In the same industry, the benchmark covers 65 companies and MEDANTA’s valuation sits above the median.
About Global Health
Global Health, listed as MEDANTA, operates in the Healthcare sector and the Hospital & Healthcare Services industry. The company’s stock is tracked on NSE and BSE through its market data, and its current share price, market capitalisation and valuation ratios are among the most visible data points for readers following Global Health Stock News.
For market participants using Univest, the company’s profile is best understood through its exact financial metrics: P/E, P/B, ROE, ROCE, EPS, book value and dividend yield. Those figures shape how Global Health Share Price is discussed in stock analysis, especially when the day’s move is a decline without a stated catalyst.
Track Global Health Share Price on Univest
Use Global Health (MEDANTA) live share-price page,Univest top decliners screener,Univest market blogs to review live stock data, top decliners and related market analysis.
Readers can track Global Health Share Price on Univest for live price updates, financial ratios, shareholding pattern, 52-week levels and market insights. Univest also brings together company news, sector context, peer comparison and fundamental data in one place for MEDANTA.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Global Health Share Price fall today?
Ans. Global Health Share Price fell 2.08% to Rs 1,404 today. The supplied data confirms the price event, but it does not establish a company-specific catalyst behind the move. The previous close was Rs 1,433.8.
What was the previous close for MEDANTA?
Ans. MEDANTA closed at Rs 1,433.80 in the previous session. Today’s close at Rs 1,404 means the stock declined by Rs 29.80, giving market watchers a clear reference for the day’s change.
How does Global Health compare with healthcare peers?
Ans. Global Health Share Price is backed by a P/E of 69.31 and ROCE of 19.38%. That places it above the industry median P/E of 47.3 and above the benchmark ROCE median of 15.84%.
What is Global Health market capitalisation?
Ans. Global Health market capitalisation stood at Rs 40,204.85 Cr. The company is classified as Large Cap, which gives useful size context when comparing MEDANTA with other hospital and healthcare services names.
What do MEDANTA’s EPS and book value show?
Ans. MEDANTA’s EPS is Rs 20.69 and book value is Rs 152.94. EPS shows earnings attributable to each share, while book value per share reflects the accounting net worth behind each share.
Is Global Health trading at a premium valuation?
Ans. Global Health Share Price sits alongside a P/E of 69.31 and a P/B of 9.38. Both are above the same-industry median values, so the stock trades at a premium to the benchmark median.
